---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-029978"
form_type: "8-K"
ticker: "BBLG"
cik: "0001419554"
company_name: "Bone Biologics Corp"
filed_at: "2024-08-02T23:59:59+00:00"
generated_at: "2026-05-31T13:26:11.591037+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Bone Biologics raises $2.1M via exercise of warrants, issues new warrants for 1.56M shares

## Summary
- Existing warrant holders exercised 781,251 shares at $2.43/share, yielding ~$2.1M gross proceeds.
- Company issued new unregistered warrants to purchase 1,562,502 shares at $2.00/share (five-year and 18-month terms).
- H.C. Wainwright acted as exclusive placement agent; fees include 7.0% cash fee and placement agent warrants.
- Net proceeds to fund clinical trials, patent portfolio, and working capital.
- Inducement transaction expected to close August 2, 2024.

## SEC filing metadata
- accession: 0001493152-24-029978
- form_type: 8-K
- ticker: BBLG
- cik: 0001419554
- company_name: Bone Biologics Corp
- filed_at: 2024-08-02T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419554/000149315224029978/0001493152-24-029978-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419554/000149315224029978/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-029978
- JSON: https://secwatch.observer/filing/0001493152-24-029978.json
- Plain text: https://secwatch.observer/filing/0001493152-24-029978.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.